Cohort evaluation of an all-oral shorter regimen for drug-resistant tuberculosis in Ecuador

Abstract Background Tuberculosis (TB) remains the leading cause of death from infectious agents globally and disproportionately affects people living with HIV. In 2023, 10.6 million TB cases were reported worldwide, including 8,200 in Ecuador. Between 2020 and 2023, TB incidence in Ecuador increased...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Adriana Chacón, Yamile Celis Bustos, Dany Martinez, Felix Chong, Clara Freile, Carla Ayala, Amadou Seck, Fatimata Bintou Sall, Corinne Simone Merle, Freddy Perez
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2026-03-01
Edice:	BMC Infectious Diseases
Témata:	Tuberculosis Multidrug-resistant Short all-oral treatment Treatment outcome Cohort Ecuador
On-line přístup:	https://doi.org/10.1186/s12879-026-13156-2
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!